CAM
LFCR icon

ClariVest Asset Management’s Lifecore Biomedical LFCR Stock Holding History

ClariVest Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,301
Closed -$163K – 580
2013
Q2 		$163K Buy
+12,301
New +$170K 0.01% 355

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClariVest Asset Management's LFCR Position: Q3 2013 in Review

ClariVest Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2013, closing a stake of 12,301 shares — an estimated $163K sold.

ClariVest Asset Management first reported a position in LFCR in Q2 2013 and held it in 1 quarter. The position peaked at $163K in Q2 2013. 125 funds tracked by Wall St. Rank hold LFCR as of Q3 2013.

  • ClariVest Asset Management reported no remaining Lifecore Biomedical position as of Q3 2013 after selling out during the quarter.
  • ClariVest Asset Management sold 12,301 Lifecore Biomedical shares in Q3 2013, an estimated $163K.
  • ClariVest Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 1 quarter.
  • ClariVest Asset Management's Lifecore Biomedical position peaked at $163K in Q2 2013.
  • 125 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2013.

Based on ClariVest Asset Management's 13F filing for Q3 2013, filed 15 Oct 2013.